Early trial data support quarterly dosing of an under-the-skin Briumvi formulation now being tested in Phase 3 for relapsing ...
The FDA has placed a clinical hold on Quantum’s application seeking clearance to begin a Phase 2 trial testing Lucid-MS in ...
The MSAA is expanding its patient-centered research network to include more than 1,000 people with MS receiving care at 20 ...
The National MS Society has released a new report detailing the lived experiences of people with MS and highlighting unmet ...
Neurophet has entered a collaboration to advance software that uses AI to examine brain MRI scans for signs characteristic of ...
World MS Day on May 30 unites advocates to push for earlier diagnoses of multiple sclerosis, better medical training, and ...
The benefits of frexalimab in people with relapsing MS have been sustained for up to three years in a clinical trial, data ...
Neuropsychiatric care in MS has seen major progress over the last 40 years, though more remains to be done, an expert in the ...
An app-based peer support program boosted self-confidence and social connection for people newly diagnosed with multiple ...
Columnist Ben Hofmeister makes a presentation at this year's meeting of the Consortium of Multiple Sclerosis Centers on MS quality of care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results